China Universal Asset Management Company’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

China Universal Asset Management Company’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,405	Closed	-$84.4K	–	455
2023 Q4	$84.4K	Buy	8,405 +6,657	+381%	+$30.2K	0.02%	304
2023 Q3	$5.03K	Buy	1,748 +855	+96%	+$3.13K	﹤0.01%	394
2023 Q2	$3.4K	Sell	893 -10	-1%	-$28	﹤0.01%	403
2023 Q1	$1.68K	Buy	903 +225	+33%	+$470	﹤0.01%	436
2022 Q4	$1.56K	Buy	678 +54	+9%	+$165	﹤0.01%	385
2022 Q3	$2K	Buy	+624	New	+$2.03K	﹤0.01%	373

China Universal Asset Management Company's GRCL Position: Q1 2024 in Review

China Universal Asset Management Company sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 8,405 shares — an estimated $84.4K sold.

China Universal Asset Management Company first reported a position in GRCL in Q3 2022 and held it in 6 quarters. The position peaked at $84.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

China Universal Asset Management Company reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
China Universal Asset Management Company sold 8,405 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $84.4K.
China Universal Asset Management Company first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2022 and held it in 6 quarters.
China Universal Asset Management Company's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $84.4K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on China Universal Asset Management Company's 13F filing for Q1 2024, filed 29 Apr 2024.